The message tested well. The field team was trained on it, and the data behind it is the brand’s strongest argument. Yet when physicians are asked what they remember, it’s not the message that comes back. This isn’t a wording problem. Efficacy messaging is convincing once recalled—the gap is structural, not creative.
This report traces that gap across 23 message themes and six years of physician responses, and explores what a message set looks like when it’s built to be remembered, not just right.
Download the Report
THE RECALL GAP
Why High-Scoring Oncology Messages Fail to Stick
Brand, insights, sales, and field operations each measure message performance differently, but they share one assumption: a message that tests well is the one HCPs will remember. In oncology, that assumption breaks down where it matters most.
Efficacy messaging scores 64.2% on physician motivation, the highest of the 23 themes ZoomRx tracks. Yet a single efficacy claim is recalled less often than a simpler fact like approval or indication. The gap is not in the wording. It sits earlier, in how the set of messages is built.
This report examines 23 oncology message themes, 3,135 efficacy messages and six years of physician responses to explain why. If you lead message strategy, training, or field execution for an oncology brand, it shows where your testing scores and real recall diverge, and what to do about it.
Why the strongest argument is not the best remembered
What separates the themes physicians hold onto from the ones they do not, and why a high effectiveness score does not predict recall.
One drafting choice that shifts recall
There is one decision inside an efficacy message that moves recall by a few points, and it is not the one most teams spend their time debating.
What happens to recall as a brand matures
How efficacy recall behaves across a product's first four years, which two themes move in the opposite direction, and when to start shifting weight between them.
Building a message set physicians can hold onto
Four principles for structuring a set, plus a stage by stage guide to which theme should lead at each point in a product's life.
ABOUT THIS RESEARCH
What 3,135 oncology messages reveal about recall
This analysis draws on ZoomRx's oncology promotional message benchmark, built from physician responses collected between January 2020 and August 2026. Every message is tagged by theme and by the clinical result it reports, then measured on both recall and effectiveness.
Recall here means whether a physician remembers a specific message being discussed once they are shown it. Effectiveness combines how much a message motivates prescribing, how believable physicians find it, and how far it sets a brand apart.
These are not opinions about what should work. They are measurements of what did, taken continuously across the category rather than from a single brand's own testing.
Oncology message themes benchmarked
Distinct efficacy messages analyzed
Efficacy message exposures
Of continuous physician fielding
About ZoomRx PET
ZoomRx Is Trusted By 100+ Leading Biopharma Companies Across The World
Promotional Effectiveness Tracking measures how your promotional activity lands with physicians. It captures message recall immediately after a conversation, tracks what is still remembered weeks later, and connects that back to prescribing behavior. The benchmark in this report comes from the same ongoing programme.
Run against your own brand, it places your efficacy claims directly on the curves in this report, so you can see where your messaging sits against the rest of oncology rather than only against itself.